Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT05615311

Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm

Conditions: Prematurity; Extreme

Sex: All

Ages: 1 Day – 4 Days

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 126

Sponsor: University of Alabama at Birmingham

Location: University of Alabama at Birmingham Birmingham Alabama

Summary

This is a masked randomized clinical trial in which extremely preterm infants fed human milk will be randomly assigned to receive either the highest (intervention group) or lowest (control group) vitamin D dose recommended during the first 14 days after birth.

Eligibility Criteria

Inclusion Criteria: * Gestational age of 28 weeks or less Exclusion Criteria: * Major congenital anomalies and infants * Terminal illness in whom decisions to withhold or limit life support have been made

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05615311). StuddyBuddy aggregates publicly available trial information.